{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:15:20Z","timestamp":1787318120294,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["20HA2003"],"award-info":[{"award-number":["20HA2003"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jiac.2022.05.007","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T08:37:00Z","timestamp":1653035820000},"page":"1266-1272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A study of trends and factors associated with therapeutic drug monitoring (TDM) implementation for arbekacin treatment using a large Japanese medical claims database"],"prefix":"10.1016","volume":"28","author":[{"given":"Saki","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4874-0377","authenticated-orcid":false,"given":"Ryo","family":"Inose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Kusama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akane","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4719-651X","authenticated-orcid":false,"given":"Masahiro","family":"Ishikane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6951-5676","authenticated-orcid":false,"given":"Yuichi","family":"Muraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2022.05.007_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/jgf2.252","article-title":"Building primary care in Japan: literature review","volume":"20","author":"Kato","year":"2019","journal-title":"J Gen Fam Med"},{"key":"10.1016\/j.jiac.2022.05.007_bib2","unstructured":"Ministry of Health, Labour and Welfare. Matters related to medical reimbursements, https:\/\/www.mhlw.go.jp\/content\/12400000\/000666093.pdf, [accessed 24 October 2021]."},{"key":"10.1016\/j.jiac.2022.05.007_bib3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2188\/jea.JE20110085","article-title":"Infection control in healthcare settings in Japan","volume":"22","author":"Morikane","year":"2012","journal-title":"J Epidemiol"},{"key":"10.1016\/j.jiac.2022.05.007_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jiac.2020.09.015","article-title":"Impact of health policy on structural requisites for antimicrobial stewardship: a nationwide survey conducted in Japanese hospitals after enforcing the revised reimbursement system for antimicrobial stewardship programs","volume":"27","author":"Maeda","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2022.05.007_bib5","first-page":"139","article-title":"Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens","volume":"6","author":"Matsumoto","year":"2014","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.jiac.2022.05.007_bib6","series-title":"Committee for the preparation of guidelines for management and treatment of infections caused by MRSA. Practical guidelines for the management and treatment of infections caused by MRSA","year":"2019"},{"key":"10.1016\/j.jiac.2022.05.007_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jiac.2013.08.008","article-title":"Clinical practice guidelines for therapeutic drug monitoring of arbekacin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring","volume":"20","author":"Okada","year":"2014","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.jiac.2022.05.007_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40780-020-00174-8","article-title":"Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin\u2014an epidemiological surveillance study using Japanese large health insurance claims database","volume":"6","author":"Imai","year":"2020","journal-title":"J. Pharm. Health Care Sci."},{"key":"10.1016\/j.jiac.2022.05.007_bib9","unstructured":"Medical data. Vision, https:\/\/www.mdv.co.jp\/ebm\/, [accessed 8 September 2021]."},{"key":"10.1016\/j.jiac.2022.05.007_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2022.05.007_bib11","unstructured":"The Japanese Society of Chemotherapy, the Japanese Society of Therapeutic Drug Monitoring. Clinical practice guidelines for therapeutic drug monitoring of antibiotics, http:\/\/www.chemotherapy.or.jp\/guideline\/tdm_es.pdf [accessed 8 November 2021]."},{"key":"10.1016\/j.jiac.2022.05.007_bib12","unstructured":"Japan nosocomial infections surveillance. Open annual report in 2019 nosocomial infections surveillance, https:\/\/janis.mhlw.go.jp\/report\/open_report\/2019\/3\/2\/zen_Open_Report_201900.pdf [accessed 20 February 2022]."},{"key":"10.1016\/j.jiac.2022.05.007_bib13","series-title":"Summary of static\/dynamic surveys of medical institutions and hospital report","year":"2017"},{"key":"10.1016\/j.jiac.2022.05.007_bib14","series-title":"Japan surveillance for infection prevention and healthcare epidemiology J-SIPHE annual report","year":"2019"},{"key":"10.1016\/j.jiac.2022.05.007_bib15","doi-asserted-by":"crossref","DOI":"10.1248\/bpb.b20-00605","article-title":"Trends of the use of anti-methicillin-resistant Staphylococcus aureus agents in Japan based on sales data from 2006 to 2015","volume":"43","author":"Goto","year":"2020","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jiac.2022.05.007_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1248\/bpb.b15-00774","article-title":"Clinical evaluation of pharmacist interventions in patients treated with anti-methicillin-resistant Staphylococcus aureus agents in a hematological ward","volume":"39","author":"Okada","year":"2016","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jiac.2022.05.007_bib17","first-page":"357","article-title":"Therapeutic drug monitoring questionnaire survey of glycopeptide agents in Japan\u2014comparison with the TDM guidelines for antimicrobial drugs","volume":"63","author":"Ueda","year":"2015","journal-title":"Jpn J Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22001568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22001568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:04:39Z","timestamp":1761159879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X22001568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1341321X22001568"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2022.05.007","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A study of trends and factors associated with therapeutic drug monitoring (TDM) implementation for arbekacin treatment using a large Japanese medical claims database","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2022.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}